Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News on Pharma

Here's Why Regeneron Pharmaceuticals Just Hit A Record High — Again

There's more than Eylea to like about Regeneron Pharmaceuticals right now, an analyst said Friday as REGN stock touched another record high.

Investors Business Daily

Why Big Pharma Led By Merck, Sanofi, Teva Are Pouring Billions Into A New Immunology Space

There's a revolution in immunology that could completely shift a paradigm biotech stocks. And Big Pharma is paying billions to get in.

Investors Business Daily

State Economics — Spotlight on New England: The Kiplinger Letter

After a better-than-expected 2023, New England states will see only modest employment growth in 2024.

Kiplinger

From analysis to the latest developments in health,
read the most diverse news in one place.

Are These 4 Biotech Stocks Worth Buying in 2024?

The need for innovative healthcare solutions, personalized medicines and treatments, and the use of advanced technologies will propel the biotech industry forward. Amid this backdrop, let’s explore the investment potential of biotech stocks TG Therapeutics (TGTX), Galapagos (GLPG), BioMarin Pharmaceutical (BMRN), and United Therapeutics (UTHR).

StockNews.com

Bayer undeterred by setback, forges ahead with US expansion

Bayer remains undeterred by setbacks as they forge ahead with plans to expand in the US market, showing resilience and determination in the face of challenges.

Top News

Hot Biotech Play Breaks Out Into By Range

As biotech stocks boom on a strong 2024 outlook following a rough two years, the XBI ETF launches a fresh breakout.

Investors Business Daily

Ambrx Biopharma soars on $2 billion takeover by Johnson & Johnson

Ambrx Biopharma is the latest cancer-drug specialist to be bought by a larger pharma over the past year.

The Street

Read news from The Economist, FT, and more,
with one subscription

Merck Hooks Harpoon Therapeutics in 0M Acquisition Spree!

Merck sets sail into new therapeutic waters with the 0 million acquisition of Harpoon Therapeutics, harnessing the power of innovation to navigate treat...

Top News

Health Ministry notifies revised Pharma manufacturing rules under schedule M to ensure quality control

Revised Schedule M of Drugs and Cosmetics Rules, 1945 notified by Union Health Ministry to ensure robust quality control for pharma and biopharmaceutical products.

The Hindu

FDA allowing drug imports from Canada to lower prescription costs

Get the latest on the FDA's decision to allow Florida to import medications from Canada, potentially reducing prescription costs for Americans. Learn about...

Top News

Novo Nordisk, IBD Stock Of The Day, Flashes Buy Signal Amid The Weight-Loss Craze

Novo Nordisk stock is Friday's IBD Stock Of The Day. Shares are in a buy zone after the firm inked deals in the weight-loss drugs space.

Investors Business Daily

US biotech company halts sales of DNA kits in Tibet, as lawmakers mull more export controls on China

Thermo Fisher, an American biotech company, has halted sales of its DNA testing products in Tibet, amid concerns that its products might have assisted the Chinese government in a surveillance campaign in the ethnic region

The Independent UK

Stock Market Skids To Start 2024 As Tesla, Apple Stumble, Mobileye Crashes: Weekly Review

The S&P 500 snapped a nine-week win streak, but tried to find support. Tesla, Apple and Mobileye were key losers.

Investors Business Daily

FDA approves program to allow Florida to import Canadian prescription drugs

State will be first to import drugs under federal program that Florida governor says could save consumers $150m in first year

The Guardian - US

Get all your
news in one place.

100’s of premium titles.
One news app.

Top News

FDA Approves Florida's Groundbreaking Prescription Drug Import Plan from Canada

FDA clears Florida's plan to import cheaper prescription drugs from Canada, marking a seismic shift in U.S. drug pricing and a win for consumers.

The Independent UK

Florida can import prescription drugs from Canada, US regulators say

Federal officials have cleared the way for Florida to begin importing cheaper prescription drugs from Canada

Investors Business Daily

Kymera Therapeutics Stock Whiplash: Shares Soar, Then Tumble After $275 Million Offering

KYMR stock rocketed and then toppled Friday after Kymera outlined its newest immune disease drugs and tacked on a $275 million offering.

The Street

Eli Lilly says obesity drugs not for 'cosmetic' use amid digital-sales push

Eli Lilly is looking to deliver its anti-obesity treatments directly to consumers while warning against their use for 'cosmetic' weight loss.

Get all your
news in one place.

100’s of premium titles.
One news app.

Chicago Sun-Times

Weed dispensary plan at old Rainforest Cafe in River North goes up in smoke

Two lawsuits sought to block the joint venture between Progressive Treatment Solutions LLC and Bio-Pharm for an outlet at 605 N. Clark St.

Kiplinger

Drugmakers to Hike Prices on 500 Drugs Soon — Report

Big drugmakers plan to raise prices on more than 500 drugs this month, according to a Reuters report.

Investors Business Daily

Eli Lilly, IBD Stock Of The Day, Strikes Bullish Pose After Closing A Key Buyout

Eli Lilly stock is Tuesday's IBD Stock Of The Day after the company wrapped its $1.4 billion takeover of Point Biopharma.

StockNews.com

3 Top-Rated Pharma Stock Picks to Consider in the New Year

The pharmaceutical industry is expected to grow rapidly due to rising global medical needs and technological advancements. With the industry expected to thrive in the coming years, it could be wise to buy Zoetis (ZTS), AstraZeneca (AZN) and Taro Pharmaceutical (TARO) for steady returns. Read more.

StockNews.com

Bullish or Bearish: 3 Pharma Options

The pharmaceutical industry’s robust outlook is driven by high healthcare spending globally, consistent R&D efforts, and the rapid adoption of advanced digital technologies. So, let’s analyze if investors should adopt a bullish or bearish stance on pharma stocks such as Tilray Brands (TLRY), CytomX Therapeutics (CTMX), and Wave Life Sciences…

The Independent UK

Consulting firm McKinsey agrees to $78 million settlement with insurers over opioids

Consulting firm McKinsey and Co. has agreed to pay $78 million to settle claims from insurers and health care funds that its marketing work with Purdue Pharma helped fuel an opioid addiction crisis

Investors Business Daily

Why CymaBay Morphed From Dollar Stock To Biotech Rocket

CymaBay is sprinting to the finish line with a treatment for a serious liver disease and CBAY stock is on a massive run.

1 … 19 20 21 22

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

World Health Organization

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.